Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese

Journal of Epidemiology

Volumn 22, Issue 6, 2012, Pages 477-483

  Nakao, Makoto ^a,b   Hosono, Satoyo ^a   Ito, Hidemi ^a   Watanabe, Miki ^a   Mizuno, Nobumasa ^a   Sato, Shigeki ^b   Yatabe, Yasushi ^a   Yamao, Kenji ^a   Ueda, Ryuzo ^b   Tajima, Kazuo ^a   Tanaka, Hideo ^a,c   Matsuo, Keitaro ^a,c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA repair gene; Pancreatic cancer; SNPs; XRCC1

Indexed keywords

APEX1 PROTEIN, HUMAN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA BINDING PROTEIN; DNA GLYCOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXOGUANINE GLYCOSYLASE 1, HUMAN; PARP1 PROTEIN, HUMAN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; ASIAN; CASE CONTROL STUDY; DNA REPAIR; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; JAPAN; MALE; MIDDLE AGED; PANCREAS TUMOR; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 84869072371     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20120010     Document Type: Article

References (35)

1. Center for Cancer Control and Information Services. Japan:N.C.C. Center for Cancer Control and Information Services,National Cancer Center; 2007.
2. Kanda J, Matsuo K, Suzuki T, Kawase T, Hiraki A, Watanabe M, et al. Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese. Cancer Sci. 2009;100:296-302.
3. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol. 2009;39:850-8.
4. Tsugane S, Inoue M. Insulin resistance and cancer:epidemiological evidence. Cancer Sci. 2010;101:1073-9.
5. Low SK, Kuchiba A, Zembutsu H, Saito A, Takahashi A, Kubo M, et al. Genome-wide association study of pancreatic cancer in Japanese population. PLoS One. 2010;5:e11824.
6. Tsukuma H, Ajiki W, Ioka A, Oshima A; Research Group of Population-Based Cancer Registries of Japan. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006;36:602-7.
7. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20:197-209.
8. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Inaba Y, et al. Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer. 2007;120:2665-71.
9. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int J Cancer. 2007;120:1993-8.
10. Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H, et al. Epidemiology of pancreatic cancer in Japan: a nested casecontrol study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol.2003;32:257-62.
11. Hruban RH, Canto MI, Goggins M, Schulick R, Klein AP.Update on familial pancreatic cancer. Adv Surg. 2010;44:293-311.
12. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res. 2009;15:740-6.
13. Duell EJ, Bracci PM, Moore JH, Burk RD, Kelsey KT, Holly EA. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1470-9.
14. Lin Y, Yagyu K, Egawa N, Ueno M, Mori M, Nakao H, et al. An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies. J Epidemiol. 2011;21:2-12.
15. McWilliams RR, Bamlet WR, de Andrade M, Rider DN,Cunningham JM, Petersen GM. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev. 2009;18:1295-302.
16. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett. 2007;245:61-8.
17. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res. 2008;68:4928-35.
18. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. 2002;62:4630-6.
19. Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, et al. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev.2006;30:284-91.
20. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 2005;162:925-42.
21. Maynard S, Schurman SH, Harboe C, de Souza-Pinto NC, Bohr VA. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis. 2009;30:2-10.
22. Mandal RK, Mittal T, Kapoor R, Mittal RD. NER and BER repair gene polymorphisms in a healthy north Indian cohort and comparison with different ethnic groups worldwide. Asian Pac J Cancer Prev. 2010;11:1601-4.
23. Caldecott KW. Single-strand break repair and genetic disease. Nat Rev Genet. 2008;9:619-31.
24. Tajima K, Hirose K, Inoue M, Takezaki T, Hamajima N, Kuroishi T. A Model of Practical Cancer Prevention for Outpatients Visiting a Hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev. 2000;1:35-47.
25. Hamajima N, Matsuo K, Saito T, Hirose K, Inoue M, Takezaki T, et al. Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II).Asian Pac J Cancer Prev. 2001;2:99-107.
26. Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Kuroishi T, et al. Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. J Clin Epidemiol. 1997;50:69-77.
27. Hill DA, Wang SS, Cerhan JR, Davis S, Cozen W, Severson RK, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood. 2006;108:3161-7.
28. Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X. Highorder interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 2007;16:84-91.
29. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965-71.
30. Marchenko YV, Carroll RJ, Lin DY, Amos CI, Gutierrez RG. Semiparametric analysis of case-control genetic data in the presence of environmental factors. Stata J. 2008;8:305-33.
31. Epstein MP, Satten GA. Inference on haplotype effects in casecontrol studies using unphased genotype data. Am J Hum Genet. 2003;73:1316-29.
32. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604-8.
33. Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, Tsurusako S, et al. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med. 2006;35:11-8.
34. Nakao M, Matsuo K, Hosono S, Ogata S, Ito H, Watanabe M, et al. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population. Cancer Sci. 2011;102:1076-80.
35. Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Kawase T, Tanaka H, et al. Anthropometric factors at age 20 years and risk of thyroid cancer. Cancer Causes Control. 2008;19:1233-42.